Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

Materialise NV

Materialise ( ($MTLS) ) has issued an announcement. On November 18, 2025, Materialise NV announced the admission of its ordinary shares to trading ...

Materialise NV Expands Market Reach with Euronext Brussels Listing

An announcement from Materialise ( ($MTLS) ) is now available. On November 14, 2025, Materialise NV held an Extraordinary Shareholders’ Meeting whe...

Materialise NV Approves Key Resolutions at Extraordinary Shareholders’ Meeting

Materialise ( ($MTLS) ) has shared an announcement. On October 30, 2025, Materialise NV announced plans to pursue an additional listing of its ordi...

Materialise NV Announces Euronext Brussels Listing and ADS Buyback Program

Materialise NV ( ($MTLS) ) has released its Q3 earnings. Here is a breakdown of the information Materialise NV presented to its investors. Material...

Materialise NV Reports Mixed Q3 2025 Results

Materialise NV (($MTLS)) announced an update on their ongoing clinical study. Materialise NV has announced a new clinical study titled Unlocking TM...

Current Quarter	$NA	Next Quarter	$NA
Current Year	$0.08	Next Year	$0.24
QoQ Growth	NaN%	YoY Growth	+200.0%
3Y EPS CAGR	+0.0%	Target Price	$9.05
Consensus	Buy	Upside	+51.6%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MTLS	$5.97	+2.05%	109.18K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MTLS	$5.97	+2.1%	109.18K
3
4
5
6

MTLS

MTLS

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Materialise NV Data in Excel

Get Materialise NV Data in Excel